Form 8-K - Current report:
SEC Accession No. 0001401708-24-000036
Filing Date
2024-03-12
Accepted
2024-03-11 17:33:05
Documents
16
Period of Report
2024-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K nstg-20240310.htm   iXBRL 8-K 40366
2 EX-10.1 nstg-2024ex101.htm EX-10.1 601181
3 EX-99.1 nstg-20248kex991.htm EX-99.1 13713
  Complete submission text file 0001401708-24-000036.txt   883727

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20240310.xsd EX-101.SCH 1948
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20240310_lab.xml EX-101.LAB 21026
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20240310_pre.xml EX-101.PRE 12027
17 EXTRACTED XBRL INSTANCE DOCUMENT nstg-20240310_htm.xml XML 2638
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

EIN.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35980 | Film No.: 24739327
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)